BioCryst forms seven-member scientific advisory board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.10 -0.07 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.17 | 52 Week High | $10.98 | |||
| Open | $8.17 | 52 Week Low | $1.63 | |||
| Day High | $8.25 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $-0.68 | |||
| Volume | 4,710,044 | |||||
